Inhibitory activity of surfactin, produced by different Bacillus subtilis subsp. subtilis strains, against Listeria monocytogenes sensitive and bacteriocin-resistant strains

Microbiological Research
Daniela C Sabaté, M Carina Audisio

Abstract

Three surfactin-producing Bacillus subtilis strains, C4, M1 and G2III, previously isolated from honey and intestines from the Apis mellifera L. bee, were phylogenetically characterized at sub-species level as B. subtilis subsp. subtilis using gyrA gene sequencing. The antagonistic effect of surfactin was studied against seven different Listeria monocytogenes strains, 6 of which were resistant to bacteriocins. Surfactin showed anti-Listeria activity against all 7 strains and a dose of 0.125 mg/mL of surfactin was enough to inhibit this pathogen. Surfactin sintetized by B. subtilis subsp. subtilis C4 inhibited the pathogen in lower concentrations, 0.125 mg/mL, followed by G2III and M1 with 0.25 and 1mg/mL, respectively. In particular, a dose of 0.125 mg/mL reduced the viability of L. monocytogenes 99/287 RB6, a bacteriocin-resistant strain, to 5 log orders. Surfactin assayed maintained anti-Listeria activity within a pH range of between 2 and 10, after heat treatment (boiling for 10 min and autoclaving at 121 °C for 15 min) and after treatment with proteolytic enzymes. These results suggest that surfactin can be used as a new tool for prevention and the control of L. monocytogenes in different environments, for example, in the fo...Continue Reading

References

Jun 1, 1992·Trends in Biotechnology·A Fiechter
Jan 1, 1995·International Journal of Food Microbiology·W H HolzapfelU Schillinger
Jan 13, 1998·Molecular Microbiology·C MolletD Raoult
Aug 15, 2001·Folia Microbiologica·K CzaczykK Gulewicz
Jan 5, 2002·Food Additives and Contaminants·A D Hitchins, R C Whiting
May 7, 2002·Canadian Journal of Microbiology·Yuming BaiBrian T Driscoll
Mar 24, 2004·Trends in Biotechnology·Pooja Singh, Swaranjit Singh Cameotra
Jun 9, 2004·Applied and Environmental Microbiology·E De ClerckP De Vos
Jun 4, 2005·Applied and Environmental Microbiology·M Carina AudisioMaría C Apella
Oct 3, 2006·International Journal of Food Microbiology·Megha Gandhi, Michael L Chikindas
Nov 28, 2006·European Journal of Pharmacology·Youn-Hwan HwangHyo-In Yun
Jun 7, 2007·Microbial Cell Factories·Muaaz Mutaz Al-AjlaniShahida Hasnain
Feb 22, 2008·Trends in Microbiology·Marc Ongena, Philippe Jacques
Apr 26, 2008·Applied Biochemistry and Biotechnology·Ahmad Mohammad Abdel-MawgoudNadia Abdel-Haleem Hassouna
Jun 3, 2008·Journal of Colloid and Interface Science·Hossein GhojavandAlireza Khodabandeh Shahraki
Jul 26, 2008·Archives of Microbiology·Augusto EtchegarayOmar Teschke
Jun 3, 2009·Letters in Applied Microbiology·Marcia NitschkeJ Contiero
Jan 15, 2010·FEMS Microbiology Letters·Olfa TabbeneFerid Limam
Apr 24, 2010·FEMS Microbiology Reviews·Jos M RaaijmakersMarc Ongena
Feb 15, 2011·Food Microbiology·Simon M Cutting

Citations

May 29, 2014·Medicinal Research Reviews·Stephen A Cochrane, John C Vederas
Jan 13, 2015·Applied Microbiology and Biotechnology·Clémence LoiseauJulien Verdon
Jan 30, 2015·Canadian Journal of Microbiology·Chandra Datta SumiYoung Tae Hahm
Sep 14, 2016·Biochimica Et Biophysica Acta·Petra UttlováGabriela Seydlová
Jan 8, 2019·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Vanessa Santana Vieira SantosBoscolli Barbosa Pereira
Mar 5, 2019·Journal of Applied Microbiology·P J NaughtonI M Banat
Dec 28, 2016·Journal of Peptide Science : an Official Publication of the European Peptide Society·María Verónica HúmpolaGeorgina Guadalupe Tonarelli
Mar 16, 2019·Frontiers in Microbiology·Simon CaulierJacques Mahillon
Dec 12, 2016·Engineering in Life Sciences·Hanen Ben AyedMoncef Nasri
Sep 9, 2020·Journal of the Science of Food and Agriculture·Zhiyun LiuFeiyun Yang
Sep 26, 2018·Applied Biochemistry and Biotechnology·Siwar SoussiFerid Limam
Nov 26, 2020·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Anusree V NairK K Vijayan
Dec 19, 2020·Beilstein Journal of Organic Chemistry·Heiko T KiesewalterÁkos T Kovács
Mar 16, 2021·Probiotics and Antimicrobial Proteins·Sungmin JungSvetoslav Dimitrov Todorov

Related Concepts

Surfactin C
Antibiotics
Natto Bacteria
Apidae
DNA, Bacterial
Honey
Hydrogen-Ion Concentration
Listeria monocytogenes
Fungus Drug Sensitivity Tests
Peptide Hydrolases

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Bacillus Cereus Infection

Bacillus Cereus is a gram-positive bacteria that is the cause of some foodborne illnesses and leads to diarrhea and vomiting. Discover the latest research on Bacillus Cereus Infection here.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.